MenAfriVac as an Antitetanus Vaccine.

Saved in:
Bibliographic Details
Title: MenAfriVac as an Antitetanus Vaccine.
Authors: Borrow R; Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom., Tang Y; Meningitis Vaccine Project, PATH, Seattle, Washington., Yakubu A; Immunization, Vaccines and Biologicals/Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland., Kulkarni PS; Serum Institute of India Ltd, Pune., LaForce FM; Serum Institute of India Ltd, Pune.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2015 Nov 15; Vol. 61 Suppl 5, pp. S570-7.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/civ512